{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:11:27Z","timestamp":1760548287212},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ymgme.2006.05.002","type":"journal-article","created":{"date-parts":[[2006,6,15]],"date-time":"2006-06-15T13:25:13Z","timestamp":1150377913000},"page":"233-238","source":"Crossref","is-referenced-by-count":10,"title":["Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients"],"prefix":"10.1016","volume":"89","author":[{"given":"Andrew D.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Jiunn","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice Y.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2006.05.002_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1566524024605798","article-title":"Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex","volume":"2","author":"Chou","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ymgme.2006.05.002_bib2","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"1521","article-title":"Glycogen storage diseases","author":"Chen","year":"2001"},{"key":"10.1016\/j.ymgme.2006.05.002_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF02537265","article-title":"Plasma and lipoprotein fatty acid composition in glycogen storage disease type I","volume":"22","author":"Levy","year":"1987","journal-title":"Lipids"},{"key":"10.1016\/j.ymgme.2006.05.002_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-2275(20)38543-6","article-title":"Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding","volume":"29","author":"Levy","year":"1988","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ymgme.2006.05.002_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1203\/00006450-198904000-00002","article-title":"Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins","volume":"25","author":"Fernandes","year":"1989","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2006.05.002_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0021-9150(94)90072-8","article-title":"Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a","volume":"110","author":"Lee","year":"1994","journal-title":"Atherosclerosis"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2006.05.002_bib7","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1007\/BF02679997","article-title":"Is glycogen storage disease 1a associated with atherosclerosis?","volume":"161","author":"Ubels","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2006.05.002_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1388-1981(01)00162-7","article-title":"Cellular cholesterol efflux","volume":"1533","author":"Fielding","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2006.05.002_bib9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.ATV.0000057572.97137.DD","article-title":"Importance of different pathways of cellular cholesterol efflux","volume":"23","author":"Yancey","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2006.05.002_bib10","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1074\/jbc.273.10.5599","article-title":"Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors","volume":"273","author":"Jian","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2006.05.002_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00041433-200406000-00008","article-title":"Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids","volume":"15","author":"Connelly","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ymgme.2006.05.002_bib12","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1161\/01.ATV.17.11.2685","article-title":"HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum","volume":"17","author":"Fournier","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2006.05.002_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1194\/jlr.M300231-JLR200","article-title":"In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux","volume":"45","author":"Yancey","year":"2004","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ymgme.2006.05.002_bib14","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2174\/1381612043384655","article-title":"The antioxidants and pro-antioxidants network: an overview","volume":"10","author":"Vertuani","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgme.2006.05.002_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0021-9150(96)06064-9","article-title":"Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men","volume":"130","author":"Nyyssonen","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2006.05.002_bib16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0891-5849(98)00160-9","article-title":"Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro","volume":"25","author":"Schlotte","year":"1998","journal-title":"Free Radic. Biol. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2006.05.002_bib17","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1007\/BF02679999","article-title":"Radical trapping in glycogen storage disease 1a","volume":"161","author":"Wittenstein","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2006.05.002_bib18","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","article-title":"Dextran sulfate\u2013Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol","volume":"28","author":"Warnick","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2006.05.002_bib19","doi-asserted-by":"crossref","first-page":"20982","DOI":"10.1074\/jbc.272.34.20982","article-title":"Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux","volume":"272","author":"Ji","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2006.05.002_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00041433-200004000-00004","article-title":"The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism","volume":"11","author":"Trigatt","year":"2000","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ymgme.2006.05.002_bib21","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1161\/01.CIR.101.20.2411","article-title":"CLA-1\/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors","volume":"101","author":"Chinetti","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2006.05.002_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/hh0302.104462","article-title":"Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice","volume":"90","author":"Braun","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymgme.2006.05.002_bib23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.ATV.20.3.721","article-title":"Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse","volume":"20","author":"Kozarsky","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2006.05.002_bib24","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1161\/01.CIR.0000093189.97429.9D","article-title":"Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2006.05.002_bib25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/01.ATV.0000083343.19940.A0","article-title":"Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells","volume":"23","author":"Covey","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2006.05.002_bib26","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.febslet.2005.07.042","article-title":"Increased cellular cholesterol efflux in glycogen storage disease type Ia mice: a potential mechanism that protects against premature atherosclerosis","volume":"579","author":"Nguyen","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2006.05.002_bib27","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1152\/physrev.00005.2005","article-title":"ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease","volume":"85","author":"Oram","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymgme.2006.05.002_bib28","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.273.5277.966","article-title":"Protection against atherogenesis in mice mediated by human apolipoprotein A-IV","volume":"273","author":"Duverger","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2006.05.002_bib29","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1172\/JCI119358","article-title":"Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV","volume":"99","author":"Cohen","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2006.05.002_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1388-1981(03)00004-0","article-title":"Apo A-IV: an update on regulation and physiologic functions","volume":"1631","author":"Stan","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2006.05.002_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/B:CARD.0000015855.02485.e3","article-title":"Cardiovascular drugs and serum uric acid","volume":"17","author":"Reyes","year":"2003","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ymgme.2006.05.002_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ejheart.2004.03.020","article-title":"The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure","volume":"7","author":"Reyes","year":"2005","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ymgme.2006.05.002_bib33","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric Acid and oxidative stress","volume":"11","author":"Glantzounis","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgme.2006.05.002_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0773.2003.pto930606.x","article-title":"Inhibition by uric acid of free radicals that damage biological molecules","volume":"93","author":"Muraoka","year":"2003","journal-title":"Pharmacol. Toxicol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719206001806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719206001806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T11:26:57Z","timestamp":1627471617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719206001806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1096719206001806"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2006.05.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}